These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3841412)

  • 1. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure].
    Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension.
    Bussien JP; Waeber B; Nussberger J; Hofbauer KG; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):130-9. PubMed ID: 3767522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
    Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
    Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
    Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies with a vascular vasopressin antagonist.
    Waeber B; Nussberger J; Hofbauer KG; Nicod P; Brunner HR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S111-6. PubMed ID: 2434764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral salt load on arginine-vasopressin secretion in normal subjects.
    Spinelli L; Golino P; Piscione F; Chiariello M; Focaccio A; Ambrosio G; Condorelli M
    Ann Clin Lab Sci; 1987; 17(5):350-7. PubMed ID: 3674741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.
    Fasanella d'Amore T; Wauters JP; Waeber B; Nussberger J; Brunner HR
    Clin Nephrol; 1985 Jun; 23(6):299-302. PubMed ID: 4028528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic changes in waking rats with acute streptozotocin diabetes after administration of the combined V2/V1 vasopressin antagonist].
    Kuznetsova LV; Medvedeva NA; Medvedev OS
    Biull Eksp Biol Med; 1993 Jun; 115(6):594-6. PubMed ID: 8374133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure.
    Price JF; Towbin JA; Denfield SW; Clunie S; Smith EO; McMahon CJ; Radovancevic B; Dreyer WJ
    Circulation; 2004 Jun; 109(21):2550-3. PubMed ID: 15148276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV; Bennett GW; Hatton R
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2007 Nov; 74(10):1466-75. PubMed ID: 17720144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure.
    Uretsky BF; Verbalis JG; Generalovich T; Valdes A; Reddy PS
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H396-402. PubMed ID: 3156513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.